RxDoctor Payments Data

Maria Roa, APRN

Family · Lake Worth, FLNPI 1407407695

Payments from drug & device makers

$1,128in general payments, 2019–2025

Across 51 payments — averaging $22.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$192
  • Daiichi Sankyo Inc.$183
  • Lilly USA, LLC$133
  • Exact Sciences$132
  • AstraZeneca$103
  • Shield Therapeutics Inc$93
  • plus $293 from 8 others

What the payments were for

  • Food & beverage$1,128100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,128 in reported general payments places this provider in the 70th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$5,172
Medicare patients
18
Services billed
67

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide66$65,891
JardianceEmpagliflozin32$40,825
FarxigaDapagliflozin Propanediol29$35,303
MounjaroTirzepatide19$27,675
EliquisApixaban12$7,766
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$2,000
Atorvastatin Calcium215$1,543
Rosuvastatin Calcium169$1,477
Novolog FlexpenInsulin Aspart12$1,264
Levothyroxine Sodium135$1,222
Omega-3 Acid Ethyl Esters16$1,195
Albuterol Sulfate HfaAlbuterol Sulfate36$919
Omeprazole51$792
Pantoprazole Sodium67$679
Losartan Potassium92$675

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$17$65,89166 claims
AstraZenecaFarxiga$103$35,30329 claims
Lilly USA, LLCMounjaro$133$27,67519 claims
PfizerEliquis$35$7,76612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 14,618 family providers in Florida.

Other family in Lake Worth

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →